Company Update

Chandra Bhagat Pharma has issued a corrigendum to its Annual General Meeting (AGM) notice, scheduled for September 1. This update specifically provides the web link to the Practicing Company Secretary's compliance certificate.

The certificate confirms that the proposed preferential issue of 6.6 Cr convertible warrants adheres to necessary requirements.

This ensures shareholders have complete information regarding the warrant allotment proposal ahead of the AGM.

The corrigendum forms an integral part of the original notice, with all other details remaining unchanged for the upcoming meeting.